CD4 and tongue neoplasm: Furthermore, we observed that supplementing α-PD-1 + α-CTLA-4 treatment with STING agonist administration into the flank tumors was associated with a decrease in the frequencies of CD4+Foxp3+ Treg as well as of MDSC expressing Arginase 1 in both flank and tongue tumors.